United Therapeutics
Clinical trials sponsored by United Therapeutics, explained in plain language.
-
Major trial tests Long-Term safety of new PAH drug
Disease control ENROLLING_BY_INVITATIONThis study aims to learn about the long-term safety and effectiveness of the drug ralinepag for adults with pulmonary arterial hypertension (PAH), a serious lung and heart condition. It is an extension study for about 1,000 people who have already taken ralinepag in a previous cl…
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New strategy aims to reverse heart damage in lung disease
Disease control OngoingThis study is testing if starting a specific medication called treprostinil early and increasing the dose quickly can improve heart function and potentially reverse heart damage in people with pulmonary arterial hypertension (PAH). It will involve about 52 participants who are al…
Phase: PHASE4 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Six-year safety check for inhaled lung fibrosis drug begins
Disease control ENROLLING_BY_INVITATIONThis study follows people who were in previous trials of an inhaled medication called treprostinil for progressive lung scarring diseases. It aims to check the long-term safety and side effects of the drug over up to six years. Only people who completed specific earlier studies a…
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC